Lv71
4030 积分 2023-11-15 加入
Neoadjuvant Treatment of Mismatch Repair–Deficient Colon Cancer — Clinically Meaningful?
12天前
已完结
Clinical benefit evaluation of drug treatment regimens for advanced lung cancer-based on ASCO-VF and ESMO-MCBS
28天前
已完结
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
1个月前
已完结
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
1个月前
已完结
[Organ preservation and watch-and-wait strategy in esophageal cancer: a promising future]
3个月前
已完结
Path Less Traveled: Targeting Rare Driver Oncogenes in Non–Small-Cell Lung Cancer
5个月前
已完结
Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases
6个月前
已完结
Sample size tables for exact single‐stage phase II designs
7个月前
已完结
Immunotherapy-Based Neoadjuvant Treatment of Advanced Microsatellite Instability–High Gastric Cancer: A Case Series
7个月前
已完结
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors
7个月前
已完结
皖公网安备34019202002308
